BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11189399)

  • 1. [Alteration and clinical significance of plasma levels of tumor necrosis factor in chronic heart failure].
    Zeng L; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):379-81. PubMed ID: 11189399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia.
    Zhao SP; Zeng LH
    Int J Cardiol; 1997 Feb; 58(3):257-61. PubMed ID: 9076551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.
    Satoh S; Oyama J; Suematsu N; Kadokami T; Shimoyama N; Okutsu M; Inoue T; Sugano M; Makino N
    Int J Cardiol; 2006 Aug; 111(3):405-12. PubMed ID: 16271779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect on endothelin and cytokines on the pathogenesis of coronary heart disease].
    Guan Y; Zhang M; Yuan H; Yang J; Wang J
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):569-71. PubMed ID: 10806772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum adiponectin level in patients of chronic pulmonary heart disease with cardiac failure].
    Shi HF; Ding YP; He HW
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2544-6. PubMed ID: 19080646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biochemical markers in chronic heart failure.
    el-Bindary EM; Darwish AZ
    East Mediterr Health J; 2001; 7(4-5):697-706. PubMed ID: 15332768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
    Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment.
    Galiñanes M; James M; Codd V; Baxi A; Hadjinikolaou L
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):332-7. PubMed ID: 18450464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.
    Cicoira M; Bolger AP; Doehner W; Rauchhaus M; Davos C; Sharma R; Al-Nasser FO; Coats AJ; Anker SD
    Cytokine; 2001 Jul; 15(2):80-6. PubMed ID: 11500083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
    Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective nocturnal oxygen therapy increases circulating level of tumor necrosis factor-alpha in heart failure.
    Guzzetti S; Fundarò C; Pecis M; Costantino G; Marchetti G; Meroni L
    J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):64-7. PubMed ID: 18268422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor necrosis factor in blood plasma and morphofunctional parameters of the hart in patients with chronic heart failure complicated by a course of ischemic heart disease. Dynamics under effect of treatment].
    Ol'binskaia LI; Ignatenko SB; Markin SS
    Ter Arkh; 2003; 75(2):54-8. PubMed ID: 12685394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.